CA2677704A1 - Polymer molding compounds containing partially neutralized agents - Google Patents

Polymer molding compounds containing partially neutralized agents Download PDF

Info

Publication number
CA2677704A1
CA2677704A1 CA002677704A CA2677704A CA2677704A1 CA 2677704 A1 CA2677704 A1 CA 2677704A1 CA 002677704 A CA002677704 A CA 002677704A CA 2677704 A CA2677704 A CA 2677704A CA 2677704 A1 CA2677704 A1 CA 2677704A1
Authority
CA
Canada
Prior art keywords
active ingredient
partially neutralized
acid
ciprofloxacin
molding composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002677704A
Other languages
English (en)
French (fr)
Inventor
Ralf Dujardin
Achim Bertsch
Heinz Pudleiner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Innovation GmbH
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2677704A1 publication Critical patent/CA2677704A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/0008—Organic ingredients according to more than one of the "one dot" groups of C08K5/01 - C08K5/59
    • C08K5/0058—Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Polymers & Plastics (AREA)
  • Vascular Medicine (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Materials For Medical Uses (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
CA002677704A 2007-02-12 2008-01-30 Polymer molding compounds containing partially neutralized agents Abandoned CA2677704A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102007006761A DE102007006761A1 (de) 2007-02-12 2007-02-12 Teilneutralisierte Wirkstoffe enthaltende Polymerformmassen
DE102007006761.7 2007-02-12
PCT/EP2008/000693 WO2008098679A1 (de) 2007-02-12 2008-01-30 Teilneutralisierte wirkstoffe enthaltende polymerformmassen

Publications (1)

Publication Number Publication Date
CA2677704A1 true CA2677704A1 (en) 2008-08-21

Family

ID=39331505

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002677704A Abandoned CA2677704A1 (en) 2007-02-12 2008-01-30 Polymer molding compounds containing partially neutralized agents

Country Status (12)

Country Link
US (1) US20100094230A1 (enExample)
EP (1) EP2120552A1 (enExample)
JP (1) JP2010518246A (enExample)
CN (1) CN101605454A (enExample)
AU (1) AU2008214875A1 (enExample)
BR (1) BRPI0807468A2 (enExample)
CA (1) CA2677704A1 (enExample)
DE (1) DE102007006761A1 (enExample)
IL (1) IL199653A0 (enExample)
MX (1) MX2009007600A (enExample)
RU (1) RU2009134058A (enExample)
WO (1) WO2008098679A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102011101980A1 (de) 2011-05-17 2012-11-22 Gt Elektrotechnische Produkte Gmbh Thermoplastische Poly(urethan-harnstoffe) mit bioziden Eigenschaften und Verfahren zu ihrer Herstellung
JP5668721B2 (ja) * 2012-05-22 2015-02-12 株式会社デンソー 可塑成形用組成物および焼成品
CA3081322A1 (en) * 2017-10-30 2019-05-09 Allvivo Vascular, Inc. Delivery systems for administration of cationic biological actives

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3023192A (en) 1958-05-29 1962-02-27 Du Pont Segmented copolyetherester elastomers
US3766146A (en) 1971-03-18 1973-10-16 Du Pont Segmented thermoplastic copolyester elastomers
BE787375A (fr) 1971-08-09 1973-02-09 Du Pont Procede pour lier un fil a filaments multiples par revetement d'un copolyester elastomere
FR2273021B1 (enExample) 1974-05-31 1977-03-11 Ato Chimie
DE2449343B2 (de) 1974-10-17 1978-06-08 Hoechst Ag, 6000 Frankfurt Formmasse auf der Basis von Oxymethylenpolymeren
FR2378058A1 (fr) 1977-01-24 1978-08-18 Ato Chimie Copolyetheresteramides stables a l'hydrolyse
DE2712987C2 (de) 1977-03-24 1981-09-24 Chemische Werke Hüls AG, 4370 Marl Verfahren zur Herstellung von thermoplastischen Polyetheresteramiden mit statistisch in der Polymerkette verteilten Einheiten der Ausgangskomponenten
DE2716004C3 (de) 1977-04-09 1987-01-22 Hüls AG, 4370 Marl Thermoplastische Formmassen auf der Basis von Polylaurinlactam und deren Verwendung zur Herstellung von Rohren
FR2401947A1 (fr) 1977-09-02 1979-03-30 Ato Chimie Procede de preparation de polyether-ester-amides sequences utilisables, entre autres, comme produits a mouler, a extruder ou a filer
DE2901774A1 (de) 1979-01-18 1980-07-24 Elastogran Gmbh Rieselfaehiges, mikrobenbestaendiges farbstoff- und/oder hilfsmittelkonzentrat auf basis eines polyurethan-elastomeren und verfahren zu seiner herstellung
JPS58206628A (ja) 1982-05-27 1983-12-01 Toray Ind Inc ポリエ−テルエステルアミドの製造方法
US5019096A (en) 1988-02-11 1991-05-28 Trustees Of Columbia University In The City Of New York Infection-resistant compositions, medical devices and surfaces and methods for preparing and using same
DE4143239A1 (de) 1991-12-31 1993-07-01 Joerg Dipl Chem Schierholz Pharmazeutische wirkstoffe enthaltende implantierbare vorrichtung aus einem polymeren material sowie verfahren zu deren herstellung
DE19638570A1 (de) 1996-09-20 1998-03-26 Bayer Ag Wirkstoffhaltige thermoplastische Polyurethane
US5906825A (en) 1997-10-20 1999-05-25 Magellan Companies, Inc. Polymers containing antimicrobial agents and methods for making and using same
DE19812160C1 (de) * 1998-03-20 1999-07-08 Bayer Ag Formkörper aus wirkstoffhaltigen thermoplastischen Polyurethanen
DE59913045D1 (de) 1998-08-06 2006-04-06 Schierholz Joerg Michael Medizinprodukte mit retardierter pharmakologischer aktivität und verfahren zu ihrer herstellung
US6455059B1 (en) * 1998-11-12 2002-09-24 Bayer Aktiengesellschaft Polyether block amides containing active substances
DE19852192C2 (de) * 1998-11-12 2003-04-24 Bayer Ag Wirkstoffhaltige aromatische Copolyester
US6921390B2 (en) 2001-07-23 2005-07-26 Boston Scientific Scimed, Inc. Long-term indwelling medical devices containing slow-releasing antimicrobial agents and having a surfactant surface
DE102005048132A1 (de) * 2005-10-06 2007-04-12 Bayer Innovation Gmbh Verfahren zur Herstellung antimikrobieller Kunststoffzusammensetzungen

Also Published As

Publication number Publication date
DE102007006761A1 (de) 2008-08-14
AU2008214875A1 (en) 2008-08-21
US20100094230A1 (en) 2010-04-15
WO2008098679A1 (de) 2008-08-21
EP2120552A1 (de) 2009-11-25
IL199653A0 (en) 2010-04-15
MX2009007600A (es) 2009-07-27
BRPI0807468A2 (pt) 2014-05-13
RU2009134058A (ru) 2011-03-20
CN101605454A (zh) 2009-12-16
JP2010518246A (ja) 2010-05-27

Similar Documents

Publication Publication Date Title
AU745052B2 (en) Aromatic copolyester containing active ingredients
CN110234673B (zh) 抗微生物热塑性聚氨酯
US6723333B1 (en) Moulded bodies made of thermoplastic polyurethane containing an active substance
CA2586166A1 (en) Antimicroboial active ingredient-containing silicone elastomers
US20100094230A1 (en) Polymer molding compounds containing partially neutralized agents
US7705073B2 (en) Process for preparation of antimicrobial plastics compositions
US20070208104A1 (en) Antimicrobial plastics composition with low elution rate and with long period of activity
KR100668568B1 (ko) 활성 물질을 포함하는 폴리에테르 블록 아미드
HK1124875A (en) Sustained-release antimicrobial plastic composition with low rate of elution
HK1036599B (en) Moulded items made from active substance-containing thermoplastic polyurethanes

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20130130